Dr. Jason Rawlings grew up in Louisville, Kentucky. He received a B.S. in Biology from Furman University. He then went on to earn a Ph.D. from the University of Kentucky where his research focused on the regulation of cytokine signal transduction during development in the fruit fly, Drosophila melanogaster. He then moved to Memphis, Tennessee where he became a Postdoctoral Fellow at St. Jude Children's Research Hospital. At St. Jude, his focus shifted to the regulation of cytokine signaling in the context of the development and function of the immune system using the laboratory mouse Mus musculus as a model organism. He incorporated genetic, molecular, and biochemical techniques to study the epigenetic mechanism(s) that regulate T lymphocyte activation and proliferation. These studies were published in The EMBO Journal and received a landslide of press. Shortly after publication, The Scientist Magazine ranked it #6 in the world in the field of Molecular Biology and named it the Editor's Choice in Immunology. In 2010, Dr. Rawlings returned to his alma mater and joined the Biology Department. At Furman, he continues the research program he developed at St. Jude. His current research focuses on determining the epigenetic mechanisms that control chromatin decondensation during T lymphocyte activation. Dr. Rawlings is currently a member of the American Association of Immunologists (AAI), the Association of Southeastern Biologists (ASB), and the Council for Undergraduate Researchers (CUR).